Table 2.
Clinical characteristics of cervical cancer survivors
| Characteristic | Cervical cancer survivor (n=104) |
|---|---|
| FIGO stage | |
| Ⅰ | 81 (77.9) |
| Ⅱ | 18 (17.3) |
| Ⅲ | 4 (3.8) |
| Ⅳ | 1 (1.0) |
| Histology | |
| Squamous cell carcinoma | 81 (77.9) |
| Adenocarcinoma | 22 (21.2) |
| Small cell carcinoma | 1 (1.0) |
| Survival period (yr) | |
| ≤ 2 | 31 (29.8) |
| > 2 to ≤ 5 | 39 (37.5) |
| > 5 | 34 (32.7) |
| Type of treatment | |
| Conization only | 14 (13.5) |
| Simple hysterectomy only | 8 (7.7) |
| Radical hysterectomy only | 43 (41.3) |
| Conization+R+C | 2 (1.9) |
| Simple hysterectomy+C | 1 (1.0) |
| Simple hysterectomy+R+C | 2 (1.9) |
| Radical hysterectomy+C | 4 (3.8) |
| Radical hysterectomy+R | 6 (5.8) |
| Radical hysterectomy+R+C | 13 (12.5) |
| Staging surgery only+R | 3 (2.9) |
| R only | 1 (1.0) |
| R+C | 7 (6.7) |
| Type of surgery | |
| Conization | 16 (15.4) |
| Simple hysterectomy | 11 (10.6) |
| Radical hysterectomy | 66 (63.5) |
| Staging surgery | 3 (2.9) |
| No surgery | 8 (7.7) |
| Status of ovaries | |
| Ovaries in situ | 79 (76.0) |
| Ovarian transposition | 1 (1.0) |
| Bilateral oophorectomy | 18 (17.3) |
| Unilateral oophorectomy | 6 (5.8) |
Values are presented as number (%). Staging surgery was defined as performance of pelvic lymphadenectomy and para-aortic lymphadenectomy without hysterectomy. FIGO, International Federation of Gynecology and Obstetrics; R, radiotherapy; C, chemotherapy.